Company news

Share this article:
Cypress Pharmaceutical has entered into a multiple generic product development and marketing agreement with Standard Chem. & Pharm. Under the terms of the deal, Standard Chem. & Pharm. has the exclusive development and manufacturing rights and Cypress Pharmaceutical, Inc. has exclusive US marketing rights of generic drug products. Other financial terms of the agreement have not been disclosed.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions